CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C19604 | BRD-K53987746 | BRD-K53987746 | -- | -- | -- | Details |
| C19605 | BRD-K53987979 | BRD-K53987979 | -- | -- | -- | Details |
| C19606 | BRD-K53988836 | BRD-K53988836 | -- | -- | -- | Details |
| C19607 | BRD-K53992608 | BRD-K53992608 | -- | -- | -- | Details |
| C19608 | BRD-K53993775 | BRD-K53993775 | -- | -- | -- | Details |
| C19609 | BRD-K53995654 | BRD-K53995654 | -- | -- | -- | Details |
| C19610 | BRD-K53997799 | BRD-K53997799 | -- | -- | -- | Details |
| C19611 | BRD-K54003455 | BRD-K54003455 | -- | -- | -- | Details |
| C19612 | BRD-K54003568 | BRD-K54003568 | -- | -- | -- | Details |
| C19613 | BRD-K54006094 | formoterol | ADRB2 | Adrenergic receptor agonist | -- | Details |
| C19614 | BRD-K54007898 | BRD-K54007898 | -- | -- | -- | Details |
| C19615 | BRD-K54010839 | BRD-K54010839 | -- | -- | -- | Details |
| C19616 | BRD-K54014179 | BRD-K54014179 | -- | -- | -- | Details |
| C19617 | BRD-K54018158 | BRD-K54018158 | -- | -- | -- | Details |
| C19618 | BRD-K54022924 | BRD-K54022924 | -- | -- | -- | Details |
| C19619 | BRD-K54023716 | BRD-K54023716 | -- | -- | -- | Details |
| C19620 | BRD-K54024474 | BRD-K54024474 | -- | -- | -- | Details |
| C19621 | BRD-K54025526 | BRD-K54025526 | -- | -- | -- | Details |
| C19622 | BRD-K54028343 | BRD-K54028343 | -- | -- | -- | Details |
| C19623 | BRD-K54028654 | trehalose | -- | -- | -- | Details |
| C19624 | BRD-K54029516 | BRD-K54029516 | -- | -- | -- | Details |
| C19625 | BRD-K54036439 | BRD-K54036439 | -- | -- | -- | Details |
| C19626 | BRD-K54042694 | BRD-K54042694 | -- | -- | -- | Details |
| C19627 | BRD-K54046891 | BRD-K54046891 | -- | -- | -- | Details |
| C19628 | BRD-K54048734 | BRD-K54048734 | -- | -- | -- | Details |
| C19629 | BRD-K54049773 | BRD-K54049773 | -- | -- | -- | Details |
| C19630 | BRD-K54051742 | BRD-K54051742 | -- | -- | -- | Details |
| C19631 | BRD-K54053991 | BRD-K54053991 | -- | -- | -- | Details |
| C19632 | BRD-K54061956 | BRD-K54061956 | -- | -- | -- | Details |
| C19633 | BRD-K54066059 | BRD-K54066059 | -- | -- | -- | Details |
| C19634 | BRD-K54067431 | BRD-K54067431 | -- | -- | -- | Details |
| C19635 | BRD-K54067509 | BRD-K54067509 | -- | -- | -- | Details |
| C19636 | BRD-K54070802 | BRD-K54070802 | -- | -- | -- | Details |
| C19637 | BRD-K54074847 | BRD-K54074847 | -- | -- | -- | Details |
| C19638 | BRD-K54079231 | BRD-K54079231 | -- | -- | -- | Details |
| C19639 | BRD-K54080903 | BRD-K54080903 | -- | -- | -- | Details |
| C19640 | BRD-K54081441 | BRD-K54081441 | -- | -- | -- | Details |
| C19641 | BRD-K54089081 | BRD-K54089081 | -- | -- | -- | Details |
| C19642 | BRD-K54092557 | BRD-K54092557 | -- | -- | -- | Details |
| C19643 | BRD-K54094468 | remoxipride | DRD2 | Dopamine receptor antagonist | -- | Details |
| C19644 | BRD-K54095730 | CMPD-1 | MAPK14 | P38 MAPK inhibitor | -- | Details |
| C19645 | BRD-K54099984 | BRD-K54099984 | -- | -- | -- | Details |
| C19646 | BRD-K54100199 | BRD-K54100199 | -- | -- | -- | Details |
| C19647 | BRD-K54100265 | BRD-K54100265 | -- | -- | -- | Details |
| C19648 | BRD-K54107674 | BRD-K54107674 | -- | -- | -- | Details |
| C19649 | BRD-K54111001 | BRD-K54111001 | -- | -- | -- | Details |
| C19650 | BRD-K54112192 | BRD-K54112192 | -- | -- | -- | Details |
| C19651 | BRD-K54115231 | BRD-K54115231 | -- | -- | -- | Details |
| C19652 | BRD-K54118345 | BRD-K54118345 | -- | -- | -- | Details |
| C19653 | BRD-K54123736 | BRD-K54123736 | -- | -- | -- | Details |
| C19654 | BRD-K54127914 | BRD-K54127914 | -- | -- | -- | Details |
| C19655 | BRD-K54132860 | BRD-K54132860 | -- | -- | -- | Details |
| C19656 | BRD-K54134201 | BRD-K54134201 | -- | -- | -- | Details |
| C19657 | BRD-K54141118 | BRD-K54141118 | -- | -- | -- | Details |
| C19658 | BRD-K54141134 | BRD-K54141134 | -- | -- | -- | Details |
| C19659 | BRD-K54142781 | cirazoline | ADRA1A | Adrenergic receptor agonist | -- | Details |
| C19660 | BRD-K54143708 | BRD-K54143708 | -- | -- | -- | Details |
| C19661 | BRD-K54145771 | BRD-K54145771 | -- | -- | -- | Details |
| C19662 | BRD-K54151058 | BRD-K54151058 | -- | -- | -- | Details |
| C19663 | BRD-K54159704 | BRD-K54159704 | -- | -- | -- | Details |
| C19664 | BRD-K54161818 | BRD-K54161818 | -- | -- | -- | Details |
| C19665 | BRD-K54166087 | BRD-K54166087 | -- | -- | -- | Details |
| C19666 | BRD-K54168141 | BRD-K54168141 | -- | -- | -- | Details |
| C19667 | BRD-K54168243 | Z-36 | -- | -- | -- | Details |
| C19668 | BRD-K54168930 | BRD-K54168930 | -- | -- | -- | Details |
| C19669 | BRD-K54173022 | BRD-K54173022 | -- | -- | -- | Details |
| C19670 | BRD-K54179080 | BRD-K54179080 | -- | -- | -- | Details |
| C19671 | BRD-K54179521 | BRD-K54179521 | -- | -- | -- | Details |
| C19672 | BRD-K54198678 | BRD-K54198678 | -- | -- | -- | Details |
| C19673 | BRD-K54199214 | BRD-K54199214 | -- | -- | -- | Details |
| C19674 | BRD-K54202584 | BRD-K54202584 | -- | -- | -- | Details |
| C19675 | BRD-K54208592 | carbaryl | -- | -- | -- | Details |
| C19676 | BRD-K54210043 | NS-1619 | KCNMA1 | Calcium channel activator | -- | Details |
| C19677 | BRD-K54211867 | BRD-K54211867 | -- | -- | -- | Details |
| C19678 | BRD-K54212583 | BRD-K54212583 | -- | -- | -- | Details |
| C19679 | BRD-K54219003 | BRD-K54219003 | -- | -- | -- | Details |
| C19680 | BRD-K54224946 | BRD-K54224946 | -- | -- | -- | Details |
| C19681 | BRD-K54233340 | dorsomorphin | PRKAA1; BMPR1A; BMPR1B | AMPK inhibitor | -- | Details |
| C19682 | BRD-K54236126 | BRD-K54236126 | -- | -- | -- | Details |
| C19683 | BRD-K54247106 | BRD-K54247106 | -- | -- | -- | Details |
| C19684 | BRD-K54247306 | BRD-K54247306 | -- | -- | -- | Details |
| C19685 | BRD-K54250149 | BRD-K54250149 | -- | -- | -- | Details |
| C19686 | BRD-K54254994 | BRD-K54254994 | -- | -- | -- | Details |
| C19687 | BRD-K54256913 | MK-1775 | WEE1 | WEE1 kinase inhibitor | -- | Details |
| C19688 | BRD-K54260552 | BRD-K54260552 | -- | -- | -- | Details |
| C19689 | BRD-K54260596 | BRD-K54260596 | -- | -- | -- | Details |
| C19690 | BRD-K54261877 | BRD-K54261877 | -- | -- | -- | Details |
| C19691 | BRD-K54262203 | BRD-K54262203 | -- | -- | -- | Details |
| C19692 | BRD-K54262262 | monobenzone | TYR | Melanin inhibitor | -- | Details |
| C19693 | BRD-K54263226 | BRD-K54263226 | -- | -- | -- | Details |
| C19694 | BRD-K54264597 | BRD-K54264597 | -- | -- | canrenoic-acid | Details |
| C19695 | BRD-K54265757 | BRD-K54265757 | -- | -- | -- | Details |
| C19696 | BRD-K54272776 | BRD-K54272776 | -- | -- | -- | Details |
| C19697 | BRD-K54278059 | BRD-K54278059 | -- | -- | -- | Details |
| C19698 | BRD-K54283240 | cefixime | -- | -- | -- | Details |
| C19699 | BRD-K54285478 | BRD-K54285478 | -- | -- | -- | Details |
| C19700 | BRD-K54285697 | BRD-K54285697 | -- | -- | -- | Details |
| C19701 | BRD-K54288605 | BRD-K54288605 | -- | -- | -- | Details |
| C19702 | BRD-K54288638 | BRD-K54288638 | -- | -- | -- | Details |
| C19703 | BRD-K54294645 | BRD-K54294645 | -- | -- | -- | Details |